Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2017

Apr 10, 2017

30320_dirs_2017-04-10_9094196f-d05b-4310-a995-89a1ff3f05dd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2017-04-06

Reporting Person: CAUSEY CHRISTOPHER (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-04-06 Common Stock M 500 $51.77 Acquired 1475 Direct
2017-04-06 Common Stock D 500 $122.00 Disposed 975 Direct
2017-04-06 Common Stock M 750 $54.77 Acquired 1725 Direct
2017-04-06 Common Stock D 750 $122.00 Disposed 975 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-04-06 Share Tracking Award $51.77 M 500 Disposed 2020-06-28 Common Stock (500) Direct
2017-04-06 Share Tracking Award $54.77 M 750 Disposed 2021-06-29 Common Stock (750) Direct

Footnotes

F1: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.